Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Saturday, May 31, 2014

Results in Phase I trial of OMP-54F28, a Wnt inhibitor targeting cancer stem cells

At the 50th Annual Meeting of the American Society for Clinical Oncology , University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 , an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells .

http://ift.tt/1pvht1I

No comments:

Post a Comment

Popular Stem Cell Roundup Posts